Fencamfamin, also known as fencamfamine is a stimulant developed by Merck in the 1960s. It is used to treat depressive daytime fatigue, lack of concentration, and lethargy, particularly in individuals with chronic medical conditions due to its favorable safety profile.
Fencamfamin acts as an indirect dopamine agonist, releasing dopamine through a mechanism similar to amphetamines but with lower potency. It primarily inhibits dopamine reuptake and does not inhibit monoamine oxidase enzymes, making it safer than some other stimulants.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | N, N-Diethyl-3-phenylbicyclo[2.2.1]heptan-2-amine hydrochloride |
|---|---|
| IUPAC Name | N, N-diethyl-3-phenylbicyclo[2.2.1]heptan-2-amine;hydrochloride |
| CAS | 7177-30-2 |
| Molecular Weight | 279.8 |
| Molecular Formula | C17H26ClN |
| SMILES | CCN(CC)C1C2CCC(C2)C1C3=CC=CC=C3.Cl |